公开(公告)号：USD974547S1

公开(公告)日：2023-01-03

申请号：US29757416

申请日：2020-11-05

Applicant: AMGEN INC.

Designer： Clare O'Malley ,  Edgar Frausto ,  Jakob Halkjaer Pedersen ,  Joshua Jay Dudman ,  Dylan Bourelle

公开(公告)号：US20220387700A1

公开(公告)日：2022-12-08

申请号：US17770326

申请日：2020-10-14

Applicant: AMGEN INC.

Inventor： Scott R. Gibson ,  Xiaotong Li ,  Nicholas J. Clark ,  Carsten Bech ,  Daniel Rojecki ,  Joshua Jay Dudman ,  Jakob Pedersen ,  Jennifer L. Sawicky ,  Laura Watson

IPC: A61M5/00 ,  A61J1/10 ,  A61J1/20 ,  A61M5/14

Abstract: A drug delivery system includes a packaging housing a first component including at least one of a drug product, a diluent, a saline solution, or an IV stabilizing solution (“IVSS”) and a second component comprising at least one of the drug product, the diluent, the saline solution, and the IVSS, the first component being different than the second component. The first component is disposed in a first container in a storage state and the first container is positioned in a first compartment of the packaging housing. The second component is disposed in a second container in a storage state and the second container is positioned in a second compartment of the packaging housing. At least one of the first compartment and the second compartment may include an individual seal and wherein each of the individual seals and the first and second compartments are sterilized.

公开(公告)号：USD958329S1

公开(公告)日：2022-07-19

申请号：US29726050

申请日：2020-02-28

Applicant: AMGEN INC.

Designer： Dylan Bourelle ,  Eric Ang-Schmid ,  Jakob Halkjaer Pedersen ,  Joshua Jay Dudman

公开(公告)号：USD1072240S1

公开(公告)日：2025-04-22

申请号：US29892241

申请日：2023-05-16

Applicant: AMGEN INC.

Designer： Dylan Bourelle ,  Edgar Frausto ,  Clare O'Malley ,  Jakob Halkjaer Pedersen ,  Joshua Jay Dudman

公开(公告)号：USD1051366S1

公开(公告)日：2024-11-12

申请号：US29909617

申请日：2023-08-08

Applicant: AMGEN INC.

Designer： Jakob Halkjaer Kvist ,  Joshua Jay Dudman

公开(公告)号：US12102808B2

公开(公告)日：2024-10-01

申请号：US17036556

申请日：2020-09-29

Applicant: AMGEN INC.

Inventor： Christian Plambech ,  Matias Melander ,  Bjarke Lykke Ludvig Svendsen ,  Joshua Jay Dudman ,  Michael Sorensen ,  Margaux Frances Boyaval ,  Avon Kuo

IPC: A61M5/315 ,  A61M5/20 ,  A61M5/32

CPC classification number: A61M5/3157 ,  A61M5/2033 ,  A61M5/3204 ,  A61M2205/581

Abstract: Drug delivery devices and related arrangements are disclosed. A drug delivery device may include a housing having an opening, a drug storage container including a delivery member with an insertion end configured to extend at least partially through the opening, and a plunger. A drive mechanism may be included for driving the plunger in a distal direction to expel a drug from the drug storage container through the delivery member upon activation. The drug delivery device may additionally include a guard moveably disposed adjacent to the opening and operably coupled to the drive mechanism for activation of the drive mechanism. A lock may be selectively engageable with the guard to limit movement of the guard in the proximal direction. An indicator may be coupled to the drive mechanism to generate an audible signal during drug delivery, and to cease generating the audible signal when drug delivery is complete.

公开(公告)号：US20230381426A1

公开(公告)日：2023-11-30

申请号：US18032759

申请日：2021-11-01

Applicant: AMGEN INC.

Inventor： Jakob Halkjaer Pedersen ,  Joshua Jay Dudman ,  Chiushun Dan ,  Kasper Friis ,  Carsten Bech ,  Adrianus Gerardus Verschuren ,  Michael John McColligan ,  Filip Saarman

IPC: A61M5/42 ,  A61M5/20 ,  A61M5/32

CPC classification number: A61M5/427 ,  A61M5/20 ,  A61M5/3287

Abstract: A drug delivery device assembly is provided, including an injector housing, a needle assembly, a drive assembly, and an alignment accessory. The injector housing may include a body with a proximal end, a distal end, and a longitudinal axis extending between the proximal end and the distal end. The needle assembly is at least partially disposed within the body and may include a syringe barrel containing a medicament and a needle or a cannula. The drive assembly is at least partially disposed within the body and operably coupled with the needle assembly to urge the medicament through the needle or cannula during an injection sequence. The needle or cannula is configured to pierce a patient's skin at an injection site. The alignment accessory includes an accessory body configured to be selectively coupled with the injector housing and an alignment aid configured to aid alignment of the accessory body with respect to the patient's skin at the injection site.

公开(公告)号：US20230381423A1

公开(公告)日：2023-11-30

申请号：US18032765

申请日：2021-11-01

Applicant: AMGEN INC.

Inventor： Jakob Halkjaer Pedersen ,  Joshua Jay Dudman

IPC: A61M5/32

CPC classification number: A61M5/3221 ,  A61M2205/581 ,  A61M2205/583 ,  A61M2205/582

Abstract: A drug delivery device assembly is provided, including an injector housing, a needle assembly, a drive assembly, and a needle shield indicator accessory. The injector housing may include a body with a proximal end, a distal end, and a longitudinal axis extending between the proximal end and the distal end, and a needle shield positioned adjacent to the distal end and movable between an extended position and a retracted position. The needle assembly is at least partially disposed within the body and may include a syringe barrel containing a medicament and a needle or a cannula. The drive assembly is at least partially disposed within the body and operably coupled with the needle assembly to urge the medicament through the needle or cannula during an injection sequence. The needle shield indicator accessory includes an accessory body configured to be selectively coupled with the injector housing and a needle shield indicator configured to indicate to a user whether the needle shield is in the retracted position.